We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Spectroscopy Technique Improves Surgery for Pediatric Epilepsy Patients

By LabMedica International staff writers
Posted on 12 Mar 2025
Print article
Image: Raman spectroscopy distinguishes normal brain tissue from dysplastic tissue in single-cell analysis (Photo courtesy of T. Tran et al., doi: 10.1117/1.BIOS.2.1.015002)
Image: Raman spectroscopy distinguishes normal brain tissue from dysplastic tissue in single-cell analysis (Photo courtesy of T. Tran et al., doi: 10.1117/1.BIOS.2.1.015002)

Epilepsy affects over 50 million people globally, with approximately half of them being children. For about one-third of these patients, seizures remain uncontrolled by medications, making surgery the only viable option to provide relief. In 60% of these drug-resistant cases, seizures originate from a specific region of the brain, making surgical removal of the affected tissue the most effective treatment. The most common cause of focal epilepsy in children is focal cortical dysplasia (FCD), with type II being the most prevalent. However, accurately identifying the epileptogenic zone (EZ) during surgery can be challenging, complicating the overall success of the procedure.

A new study offers a promising approach to improving surgical precision through the use of Raman spectroscopy, a non-invasive technique that analyzes the chemical composition of tissues. The collaborative study, conducted by researchers from Polytechnique Montréal (Quebec, Canada), applied Raman microspectroscopy to tissue samples from pediatric patients diagnosed with FCD type II. By examining the biochemical signatures of individual cells, the researchers successfully distinguished abnormal FCD tissue from healthy brain cells with remarkable accuracy. The method was able to identify FCD tissue with 96% accuracy and differentiate between two subtypes of FCD type II with 92% accuracy.

These findings, published in Biophotonics Discovery, suggest that Raman spectroscopy, when used during surgery with a fiber optics system, could provide real-time guidance for surgeons to accurately identify and remove only the affected tissue, preserving healthy brain areas. In addition to improving surgical outcomes, the technique offers valuable insights into the biochemical changes that may contribute to the development of epilepsy. This innovative approach could ultimately improve seizure control and surgical success in children suffering from drug-resistant epilepsy.

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Pipet Controller
Stripettor Pro
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.